Top Videos
Top Searches
Mood & Genres
Autumn
Black Lives Matter
Chill
Christmas
Commute
Energy boosters
Feel-Good
Focus
Party
Romance
Sad
Sleep
Workout
African
Arabic
Blues
Bollywood & Indian
Classical
Country and Americana
Dance and electronic
Decades
Family
Folk and acoustic
German Hip-Hop
German Pop
Hip-Hop
Indie and alternative
J-Pop
Jazz
K-Pop
Latin
Mandopop & Cantopop
Metal
Pop
R&B and Soul
Reggae and Caribbean
Rock
Schlager
Soundtracks and musicals
How Personalized Is Myeloma Treatment and How Is Changing? Introducing the Individual Risk Model
55:29
|
Download MP3
Related Videos
Setting Up Your Expectations For Having Myeloma
Overview of HealthTree Programs for Multiple Myeloma
HealthTree Podcast for Multiple Myeloma: Dr. Sergio Giralt, MSKCC
HealthTree Podcast for Multiple Myeloma: Dr. Rodger Tiedemann, UHN
DREAMM‑3 - Blenrep (Belmaf) Vs PomDex For Relapsed/Refractory Myeloma | Katja Weisel, MD | ASCO 2023
The Current Standard of Care in the Post-Transplant Setting | Fredrik Schjesvold, MD, PhD | IMS 2024
The Future of Myeloma Drug Development | Dickran Kazandjian, MD
Talquetamab in Myeloma: Results from HealthTree Qualitative Research | Beth Faiman | #ASH24
An Introduction to HealthTree for Multiple Myeloma
HealthTree Study: Dexamethasone's Impact on Eye Health in Myeloma | Rahul Banerjee, MD | IMS 2024
CAR-T Therapy, CARTITUDE-1 ciltacabtagene autoleucel in RRMM Patients | Yi Lin, MD, PhD | ASCO 2023
Genomic Profiling in High-Risk Smoldering Myeloma | Benjamin Diamond, MD | ASH 2023
Know Your Myeloma Therapy: What's Available for Maintenance Therapy?
Real Cancer Stories: Janet Schurmann
Results of Bispecific Antibody Combination in Advanced Myeloma | Yael Cohen, MD | ASCO 2023
HealthTree Podcast for Multiple Myeloma: Dr.Frits van Rhee, UAMS
Myeloma and Dexamethasone: Insights on Tapering, Dose Intensity, and Eye Health from New Research
Is MRD Negativity the Goal of Myeloma Treatment?
Treating High Risk Multiple Myeloma an Evidence-Based Approach | Katja Weisel, MD | IMS 2024
About
FAQ
DMCA
Disclaimer
Privacy
Terms
Contact
Article
Tubidy
© 2024 Tubidy
